gsk6097608,bevacizumab
gsk,roche
['lung', 'gsk6097608', 'nsclc', 'friends', 'bevacizumab', 'library', 'ca,022,i', 'solid tumor', 'sclc', 'gsk']
cd226 axis is to be followed with anti tigit +/- cd96 and +/- pvrig combinations...still in phase i/ii in lung for safety and efficacy data...quite exciting area and nice session with my colleagues/friends at #esmoimmuno22 
Thoracic Oncologist - Head of Thoracic Group, Department of Medical Oncology - Institut Gustave Roussy (IGR) - Villejuif - France ???? and CICT member